West Pharmaceutical Services Net Profit Margin 2010-2024 | WST

Current and historical net profit margin for West Pharmaceutical Services (WST) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. West Pharmaceutical Services net profit margin for the three months ending March 31, 2024 was .
West Pharmaceutical Services Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-03-31 $2.93B $0.57B 19.40%
2023-12-31 $2.95B $0.59B 20.10%
2023-09-30 $2.93B $0.56B 19.10%
2023-06-30 $2.87B $0.52B 18.10%
2023-03-31 $2.88B $0.55B 19.17%
2022-12-31 $2.89B $0.59B 20.33%
2022-09-30 $2.91B $0.63B 21.73%
2022-06-30 $2.93B $0.69B 23.46%
2022-03-31 $2.88B $0.69B 23.77%
2021-12-31 $2.83B $0.66B 23.37%
2021-09-30 $2.68B $0.61B 22.82%
2021-06-30 $2.52B $0.52B 20.53%
2021-03-31 $2.33B $0.42B 18.14%
2020-12-31 $2.15B $0.35B 16.07%
2020-09-30 $2.04B $0.31B 15.26%
2020-06-30 $1.95B $0.29B 14.65%
2020-03-31 $1.89B $0.26B 13.76%
2019-12-31 $1.84B $0.24B 13.09%
2019-09-30 $1.79B $0.23B 12.78%
2019-06-30 $1.77B $0.23B 12.90%
2019-03-31 $1.75B $0.22B 12.49%
2018-12-31 $1.72B $0.21B 12.05%
2018-09-30 $1.71B $0.16B 9.05%
2018-06-30 $1.68B $0.15B 9.00%
2018-03-31 $1.63B $0.13B 8.23%
2017-12-31 $1.60B $0.15B 9.44%
2017-09-30 $1.57B $0.19B 12.13%
2017-06-30 $1.55B $0.18B 11.46%
2017-03-31 $1.54B $0.18B 11.92%
2016-12-31 $1.51B $0.14B 9.54%
2016-09-30 $1.49B $0.14B 9.28%
2016-06-30 $1.46B $0.10B 7.01%
2016-03-31 $1.43B $0.09B 5.96%
2015-12-31 $1.40B $0.10B 6.85%
2015-09-30 $1.39B $0.09B 6.76%
2015-06-30 $1.40B $0.12B 8.77%
2015-03-31 $1.41B $0.13B 9.43%
2014-12-31 $1.42B $0.13B 8.93%
2014-09-30 $1.42B $0.12B 8.48%
2014-06-30 $1.40B $0.12B 8.28%
2014-03-31 $1.38B $0.11B 7.84%
2013-12-31 $1.37B $0.11B 8.25%
2013-09-30 $1.35B $0.11B 8.16%
2013-06-30 $1.31B $0.10B 7.48%
2013-03-31 $1.29B $0.08B 6.51%
2012-12-31 $1.27B $0.08B 6.39%
2012-09-30 $1.24B $0.08B 6.37%
2012-06-30 $1.23B $0.08B 6.59%
2012-03-31 $1.21B $0.09B 7.01%
2011-12-31 $1.19B $0.08B 6.38%
2011-09-30 $1.17B $0.06B 5.37%
2011-06-30 $1.15B $0.06B 5.56%
2011-03-31 $1.13B $0.07B 5.87%
2010-12-31 $1.11B $0.07B 5.97%
2010-09-30 $1.12B $0.08B 7.14%
2010-06-30 $1.11B $0.08B 7.12%
2010-03-31 $1.09B $0.08B 7.08%
2009-12-31 $1.06B $0.07B 6.82%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $24.159B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $72.887B 20.45
Becton Dickinson (BDX) United States $66.122B 18.71
Cardinal Health (CAH) United States $23.477B 13.43
Align Technology (ALGN) United States $19.244B 37.15
Cooper (COO) United States $18.860B 28.54
Labcorp (LH) United States $16.830B 14.49
Henry Schein (HSIC) United States $9.184B 16.34
DENTSPLY SIRONA (XRAY) United States $5.702B 14.76
Merit Medical Systems (MMSI) United States $4.760B 26.09
CONMED (CNMD) United States $2.281B 20.69
Patterson (PDCO) United States $2.145B 10.27
STAAR Surgical (STAA) United States $2.022B 77.66
Atrion (ATRI) United States $0.815B 43.51
Lifevantage (LFVN) United States $0.096B 12.34
Pro-Dex (PDEX) United States $0.067B 34.03
Biolase (BIOL) United States $0.006B 0.00